Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2025 · 10-Q
Revenue$1.39M$1.39M+0.7% vs Q2 2024 Net Income-$2.27M-$2.27MN/M vs Q2 2024 EPS Diluted-$0.44-$0.44N/M vs Q2 2024 Gross Profit$771,061+97.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$56,144N/M Free Cash Flowderived-$59,315N/M Margins · derivedGross margin55.6%+27.3 pt vs Q2 2024
Operating margin-193.3%+16.3 pt vs Q2 2024
Net margin-163.8%+43.5 pt vs Q2 2024
ended Mar 31, 2025 · filed May 13, 2025 · 43 d after period end